| Ytd | -10.51% | |
| 1y | -40.54% |
| Open | 2.55 | Prev Close | 2.60 | Low | 2.55 | High | 2.65 | Mkt Cap | 21.09M |
| Vol | 20.07K | Avg Vol | 136.78K | EPS | -6.66 | P/E | -0.40 | Forward P/E | -0.10 |
| Beta | 1.01 | Short Ratio | 8.34 | Inst. Own | 34.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.58 | 200-d Avg | 3.02 | 1yr Est | 5.67 |
Cellectar Biosciences, Inc. (NASDAQ: CLRB - Get Free Report) has been given an average rating of "Mo
FLORHAM PARK, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a
Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Multi
Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Mult
Approximately 80% Major Response Rate and Duration of Response Exceeding 16 Months in Subset Analysi
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript
Announced Positive 12-month Follow-on Data for Iopofosine I 131 in relapsed/refractory Waldenström M
FLORHAM PARK, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a l
Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism
Cellectar Biosciences Inc (NASDAQ:CLRB) shares are down during Wednesday's premarket session after t
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 e
Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares are up during Tuesday's trading session as the comp
83.6% ORR and 61.8% MRR achieved in heavily pretreated population with median duration of response o
Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management,
Study will evaluate tumor-specific uptake, safety, tolerability, and preliminary efficacy signals of
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript
On track to submit Conditional Marketing Authorization for iopofosine I 131 to European Medicines Ag
FLORHAM PARK, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a
Strengthens Protection Around Broad Portfolio of Cancer-Targeting Drug Conjugates and Enabling Techn
Following Guidance from the European Medicines Agency's (EMA) Scientific Advice Working Party (SAWP)
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly los
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
During Tuesday's trading, 505 companies set new 52-week lows.
On Friday morning, 155 companies achieved new lows for the year.
Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thur., May 16, 2019
60 Biggest Movers From Yesterday
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018